Results 121 to 130 of about 5,120 (192)

Engineering multispecific antibodies with complete killing selectivity through the closed-loop integration of machine learning and high-throughput experimentation. [PDF]

MAbs
Grace J, Colin PY, Foxler D, Haynes W, Howsham C, Kassimatis L, Mavrogonatou L, Mighell R, McClory J, Mullin M, Ogola T, Townsend A, Ravi S, Wossnig L, van Heeke G.   +14 more
europepmc   +1 more source

Camelid VHHs as a Versatile Platform for Combating Viral Infections. [PDF]

Pharmaceuticals (Basel)
Mufrrih M, Alandijany TA.
europepmc   +1 more source

Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives. [PDF]

Front Immunol
Lopatnikova JA, Sennikov SV.
europepmc   +1 more source

Nanobodies in biomedicine: from molecular characteristics to fabrication and clinical translation. [PDF]

Mil Med Res
Cao CK, Xu XY, Liang F, Yao M, Chen YY, Li XK, Su ZJ.   +6 more
europepmc   +1 more source

The emerging role of aptamers in targeted cancer immunotherapy. [PDF]

Mol Ther Oncol
Zhu S, Xu R, Xu H, Wang Y, Wang L, He N, Wang HH, Ren X.   +7 more
europepmc   +1 more source

A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research. [PDF]

Antibodies (Basel)
Prabakaran P, Ying T, Li W.
europepmc   +1 more source

Immune cell engagers in lung cancer. [PDF]

Front Immunol
Kang J, Zhang M, He Y, Chen J, Liu X, Lv Q.   +5 more
europepmc   +1 more source

Advancing immunotherapy via multiple immune cells co-engagement. [PDF]

Front Immunol
Li H, Zhang Y, Wei Q, Sun Q, Lin F, Chen PR.   +5 more
europepmc   +1 more source

Mapping the nonribosomal specificity code through promiscuity-guided A-domain engineering. [PDF]

Chem Sci
Stanišić A, Svensson CM, Müll M, Bernal FA, Zeihe H, Ettelt U, Kries H.   +6 more
europepmc   +1 more source

A comprehensive evaluation of the human Tg32 and Tg276 FcRn transgenic mouse and non-human primate models for predicting antibody pharmacokinetics in human. [PDF]

MAbs
Gajewska M, Kiffe M, Calonder C, Engelhardt V, Pou I Miralbell C, Gonzalo-Gil E, Christianson G, Bethur N, Flora A.   +8 more
europepmc   +1 more source